Perimeter Net Receivables vs Total Liab Analysis

PINK Stock

CAD 0.46 0.01 2.13%

Perimeter Medical financial indicator trend analysis is much more than just breaking down Perimeter Medical Imaging prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Perimeter Medical Imaging is a good investment. Please check the relationship between Perimeter Medical Net Receivables and its Total Liab accounts. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Perimeter Medical Imaging. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in industry.

Net Receivables vs Total Liab

Net Receivables vs Total Liab Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Perimeter Medical Imaging Net Receivables account and Total Liab. At this time, the significance of the direction appears to have strong contrarian relationship.

The correlation between Perimeter Medical's Net Receivables and Total Liab is -0.6. Overlapping area represents the amount of variation of Net Receivables that can explain the historical movement of Total Liab in the same time period over historical financial statements of Perimeter Medical Imaging, assuming nothing else is changed. The correlation between historical values of Perimeter Medical's Net Receivables and Total Liab is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Net Receivables of Perimeter Medical Imaging are associated (or correlated) with its Total Liab. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Total Liab has no effect on the direction of Net Receivables i.e., Perimeter Medical's Net Receivables and Total Liab go up and down completely randomly.

Correlation Coefficient

-0.6

Relationship Direction	Negative
Relationship Strength	Weak

View All Relationships

Net Receivables

Total Liab

The total amount of all liabilities that a company has, including both short-term and long-term liabilities.

Most indicators from Perimeter Medical's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Perimeter Medical Imaging current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Perimeter Medical Imaging. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in industry.

Selling General Administrative is likely to climb to about 5.7 M in 2025, whereas Issuance Of Capital Stock is likely to drop 0.00 in 2025.

	2024	2025 (projected)
Depreciation And Amortization	954.1K	1.0M
Interest Income	9.0K	7.1K

Depreciation And Amortization Interest Income

Perimeter Medical fundamental ratios Correlations

	Other Current Liab	Total Current Liabilities	Other Liab	Net Tangible Assets	Retained Earnings	Accounts Payable	Net Receivables	Total Current Assets	Common Stock	Property Plant Equipment	Total Assets	Short Long Term Debt Total	Total Stockholder Equity	Property Plant And Equipment Net	Current Deferred Revenue	Net Debt	Cash	Non Current Assets Total	Long Term Debt	Cash And Short Term Investments	Common Stock Shares Outstanding	Non Current Liabilities Total	Capital Lease Obligations	Other Current Assets	Other Stockholder Equity	Total Liab
Other Current Liab		-0.31	-0.55	0.57	-0.7	0.69	0.78	0.88	0.74	0.6	0.89	-0.57	0.72	0.8	-0.55	-0.75	0.88	0.8	-0.9	0.86	0.84	-0.77	0.88	0.71	0.52	-0.39
Total Current Liabilities	-0.31		0.77	-0.95	0.73	-0.67	-0.52	-0.68	-0.75	-0.83	-0.69	0.94	-0.85	-0.66	-0.22	0.82	-0.66	-0.66	0.46	-0.68	-0.75	0.4	-0.72	-0.84	-0.88	0.98
Other Liab	-0.55	0.77		-0.87	0.85	-0.94	-0.69	-0.77	-0.84	-0.98	-0.79	0.9	-0.88	-0.77	0.01	0.86	-0.76	-0.77	0.64	-0.78	-0.83	0.54	-0.81	-0.85	-0.84	0.88
Net Tangible Assets	0.57	-0.95	-0.87		-0.88	0.8	0.74	0.84	0.91	0.9	0.87	-1.0	0.97	0.85	0.0	-0.95	0.84	0.85	-0.7	0.85	0.9	-0.58	0.88	0.93	0.91	-0.97
Retained Earnings	-0.7	0.73	0.85	-0.88		-0.85	-0.93	-0.8	-0.98	-0.84	-0.85	0.88	-0.91	-0.96	0.34	0.86	-0.79	-0.96	0.86	-0.79	-0.92	0.84	-0.9	-0.94	-0.89	0.81
Accounts Payable	0.69	-0.67	-0.94	0.8	-0.85		0.73	0.79	0.82	0.94	0.82	-0.83	0.84	0.82	-0.28	-0.82	0.78	0.82	-0.77	0.78	0.88	-0.66	0.87	0.87	0.76	-0.77
Net Receivables	0.78	-0.52	-0.69	0.74	-0.93	0.73		0.76	0.95	0.67	0.81	-0.72	0.82	0.97	-0.54	-0.77	0.76	0.97	-0.92	0.75	0.86	-0.89	0.85	0.83	0.76	-0.6
Total Current Assets	0.88	-0.68	-0.77	0.84	-0.8	0.79	0.76		0.85	0.83	1.0	-0.85	0.93	0.84	-0.18	-0.96	1.0	0.84	-0.82	0.99	0.94	-0.66	0.96	0.86	0.75	-0.73
Common Stock	0.74	-0.75	-0.84	0.91	-0.98	0.82	0.95	0.85		0.83	0.89	-0.9	0.95	0.98	-0.32	-0.9	0.85	0.98	-0.88	0.85	0.94	-0.81	0.92	0.93	0.89	-0.82
Property Plant Equipment	0.6	-0.83	-0.98	0.9	-0.84	0.94	0.67	0.83	0.83		0.84	-0.92	0.89	0.77	0.01	-0.88	0.81	0.77	-0.64	0.82	0.88	-0.59	0.86	0.91	0.89	-0.9
Total Assets	0.89	-0.69	-0.79	0.87	-0.85	0.82	0.81	1.0	0.89	0.84		-0.87	0.95	0.88	-0.23	-0.97	0.99	0.88	-0.86	0.99	0.96	-0.7	0.98	0.89	0.78	-0.75
Short Long Term Debt Total	-0.57	0.94	0.9	-1.0	0.88	-0.83	-0.72	-0.85	-0.9	-0.92	-0.87		-0.97	-0.84	-0.01	0.95	-0.84	-0.84	0.69	-0.86	-0.9	0.57	-0.88	-0.93	-0.91	0.98
Total Stockholder Equity	0.72	-0.85	-0.88	0.97	-0.91	0.84	0.82	0.93	0.95	0.89	0.95	-0.97		0.91	-0.12	-0.99	0.93	0.91	-0.81	0.94	0.94	-0.64	0.94	0.92	0.87	-0.9
Property Plant And Equipment Net	0.8	-0.66	-0.77	0.85	-0.96	0.82	0.97	0.84	0.98	0.77	0.88	-0.84	0.91		-0.5	-0.87	0.84	1.0	-0.95	0.83	0.94	-0.85	0.93	0.91	0.81	-0.73
Current Deferred Revenue	-0.55	-0.22	0.01	0.0	0.34	-0.28	-0.54	-0.18	-0.32	0.01	-0.23	-0.01	-0.12	-0.5		0.1	-0.19	-0.5	0.67	-0.15	-0.33	0.64	-0.35	-0.25	-0.01	-0.15
Net Debt	-0.75	0.82	0.86	-0.95	0.86	-0.82	-0.77	-0.96	-0.9	-0.88	-0.97	0.95	-0.99	-0.87	0.1		-0.96	-0.87	0.8	-0.97	-0.93	0.59	-0.94	-0.89	-0.81	0.87
Cash	0.88	-0.66	-0.76	0.84	-0.79	0.78	0.76	1.0	0.85	0.81	0.99	-0.84	0.93	0.84	-0.19	-0.96		0.84	-0.83	1.0	0.92	-0.62	0.94	0.83	0.71	-0.71
Non Current Assets Total	0.8	-0.66	-0.77	0.85	-0.96	0.82	0.97	0.84	0.98	0.77	0.88	-0.84	0.91	1.0	-0.5	-0.87	0.84		-0.95	0.83	0.94	-0.85	0.93	0.91	0.81	-0.73
Long Term Debt	-0.9	0.46	0.64	-0.7	0.86	-0.77	-0.92	-0.82	-0.88	-0.64	-0.86	0.69	-0.81	-0.95	0.67	0.8	-0.83	-0.95		-0.81	-0.89	0.85	-0.9	-0.81	-0.63	0.54
Cash And Short Term Investments	0.86	-0.68	-0.78	0.85	-0.79	0.78	0.75	0.99	0.85	0.82	0.99	-0.86	0.94	0.83	-0.15	-0.97	1.0	0.83	-0.81		0.92	-0.6	0.94	0.83	0.73	-0.74
Common Stock Shares Outstanding	0.84	-0.75	-0.83	0.9	-0.92	0.88	0.86	0.94	0.94	0.88	0.96	-0.9	0.94	0.94	-0.33	-0.93	0.92	0.94	-0.89	0.92		-0.81	1.0	0.97	0.87	-0.81
Non Current Liabilities Total	-0.77	0.4	0.54	-0.58	0.84	-0.66	-0.89	-0.66	-0.81	-0.59	-0.7	0.57	-0.64	-0.85	0.64	0.59	-0.62	-0.85	0.85	-0.6	-0.81		-0.79	-0.81	-0.73	0.46
Capital Lease Obligations	0.88	-0.72	-0.81	0.88	-0.9	0.87	0.85	0.96	0.92	0.86	0.98	-0.88	0.94	0.93	-0.35	-0.94	0.94	0.93	-0.9	0.94	1.0	-0.79		0.95	0.82	-0.78
Other Current Assets	0.71	-0.84	-0.85	0.93	-0.94	0.87	0.83	0.86	0.93	0.91	0.89	-0.93	0.92	0.91	-0.25	-0.89	0.83	0.91	-0.81	0.83	0.97	-0.81	0.95		0.94	-0.88
Other Stockholder Equity	0.52	-0.88	-0.84	0.91	-0.89	0.76	0.76	0.75	0.89	0.89	0.78	-0.91	0.87	0.81	-0.01	-0.81	0.71	0.81	-0.63	0.73	0.87	-0.73	0.82	0.94		-0.9
Total Liab	-0.39	0.98	0.88	-0.97	0.81	-0.77	-0.6	-0.73	-0.82	-0.9	-0.75	0.98	-0.9	-0.73	-0.15	0.87	-0.71	-0.73	0.54	-0.74	-0.81	0.46	-0.78	-0.88	-0.9

Click cells to compare fundamentals

Perimeter Medical Account Relationship Matchups

Perimeter Medical fundamental ratios Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Other Current Liab	1.2M	1.9M	5.4M	4.6M	5.3M	3.2M
Total Current Liabilities	1.8M	2.1M	8.0M	6.9M	6.2M	7.0M
Retained Earnings	(47.3M)	(64.0M)	(59.3M)	(96.7M)	(87.1M)	(91.4M)
Accounts Payable	2.0M	1.2M	2.4M	2.2M	2.6M	1.9M
Net Receivables	604.3K	1.3M	2.0M	3.1M	3.6M	3.7M
Total Current Assets	13.1M	7.7M	31.5M	23.2M	26.7M	14.8M
Common Stock	48.5M	62.5M	80.8M	107.9M	124.1M	130.3M
Total Assets	13.2M	10.0M	34.6M	27.1M	31.1M	19.2M
Short Long Term Debt Total	400.8K	441.2K	325.7K	254.4K	228.9K	217.5K
Total Stockholder Equity	10.8M	7.4M	26.1M	19.9M	22.8M	24.0M
Property Plant And Equipment Net	83.8K	2.2M	3.1M	3.9M	4.5M	4.7M
Current Deferred Revenue	515.4K	112.6K	103.7K	49.0K	44.1K	41.9K
Net Debt	(9.6M)	(4.3M)	(28.1M)	(18.2M)	(16.4M)	(15.5M)
Cash	10.0M	4.7M	28.4M	18.4M	21.2M	13.8M
Non Current Assets Total	86.4K	2.2M	3.1M	3.9M	4.5M	4.7M
Cash And Short Term Investments	11.7M	5.1M	28.4M	18.4M	21.2M	14.3M
Common Stock Shares Outstanding	27.2M	44.1M	60.6M	64.7M	74.4M	46.1M
Liabilities And Stockholders Equity	13.2M	10.0M	34.6M	27.1M	31.1M	19.2M
Non Current Liabilities Total	580.0K	414.7K	447.4K	187.7K	168.9K	337.7K
Capital Lease Obligations	61.1K	119.3K	205.6K	192.9K	221.8K	132.3K
Other Current Assets	765.8K	1.3M	1.0M	1.5M	1.7M	1.1M
Other Stockholder Equity	9.4M	8.8M	6.6M	10.1M	11.6M	8.8M
Total Liab	2.4M	2.6M	8.5M	7.1M	6.4M	6.3M
Net Invested Capital	11.1M	6.1M	26.2M	15.1M	17.3M	12.4M
Property Plant And Equipment Gross	185.5K	1.9M	4.0M	4.5M	5.1M	5.4M
Capital Stock	48.5M	47.6M	80.8M	81.8M	94.1M	60.8M
Net Working Capital	11.3M	4.4M	23.5M	12.3M	14.2M	7.8M
Short Term Debt	87.3K	180.4K	150.2K	66.7K	60.0K	57.0K

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for Perimeter Stock Analysis

When running Perimeter Medical's price analysis, check to measure Perimeter Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Perimeter Medical is operating at the current time. Most of Perimeter Medical's value examination focuses on studying past and present price action to predict the probability of Perimeter Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Perimeter Medical's price. Additionally, you may evaluate how the addition of Perimeter Medical to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC